HK1033765A1 - Detection of neoplasia by analysis of saliva - Google Patents

Detection of neoplasia by analysis of saliva

Info

Publication number
HK1033765A1
HK1033765A1 HK01104291.7A HK01104291A HK1033765A1 HK 1033765 A1 HK1033765 A1 HK 1033765A1 HK 01104291 A HK01104291 A HK 01104291A HK 1033765 A1 HK1033765 A1 HK 1033765A1
Authority
HK
Hong Kong
Prior art keywords
detection
saliva
analysis
neoplasia
nucleic acids
Prior art date
Application number
HK01104291.7A
Other languages
English (en)
Inventor
David Sidransky
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Publication of HK1033765A1 publication Critical patent/HK1033765A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
HK01104291.7A 1998-03-10 2001-06-20 Detection of neoplasia by analysis of saliva HK1033765A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/038,637 US6235470B1 (en) 1993-11-12 1998-03-10 Detection of neoplasia by analysis of saliva
PCT/US1999/005220 WO1999046408A1 (en) 1998-03-10 1999-03-10 Detection of neoplasia by analysis of saliva

Publications (1)

Publication Number Publication Date
HK1033765A1 true HK1033765A1 (en) 2001-09-21

Family

ID=21901047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104291.7A HK1033765A1 (en) 1998-03-10 2001-06-20 Detection of neoplasia by analysis of saliva

Country Status (10)

Country Link
US (4) US6235470B1 (ja)
EP (1) EP1062366B1 (ja)
JP (2) JP2002505888A (ja)
AT (1) ATE433498T1 (ja)
AU (1) AU769035B2 (ja)
CA (1) CA2323060A1 (ja)
DE (1) DE69940969D1 (ja)
HK (1) HK1033765A1 (ja)
NO (1) NO20004504L (ja)
WO (1) WO1999046408A1 (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235470B1 (en) * 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
AU726045B2 (en) * 1996-08-28 2000-10-26 Johns Hopkins University School Of Medicine, The Method for detecting cell proliferative disorders
US7888324B2 (en) * 2001-08-01 2011-02-15 Genzyme Corporation Antisense modulation of apolipoprotein B expression
US7407943B2 (en) * 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
CN1558956A (zh) * 2001-12-14 2004-12-29 \ 用于癌症预测和诊断的染色定向的分子分析
US20060009410A1 (en) * 2002-11-13 2006-01-12 Crooke Rosanne M Effects of apolipoprotein B inhibition on gene expression profiles in animals
US7511131B2 (en) 2002-11-13 2009-03-31 Genzyme Corporation Antisense modulation of apolipoprotein B expression
EP1585974B1 (en) 2003-01-24 2013-02-27 University of Utah Methods of predicting mortality risk by determining telomere length
WO2005089414A2 (en) * 2004-03-17 2005-09-29 The Johns Hopkins University Neoplasia diagnostic compositions and methods of use
US20050287558A1 (en) 2004-05-05 2005-12-29 Crooke Rosanne M SNPs of apolipoprotein B and modulation of their expression
DK1786472T3 (da) * 2004-08-10 2013-04-15 Genzyme Corp Antisense-modulering af apolipoprotein B-ekspression
AU2007258117B2 (en) 2006-05-05 2013-05-30 Isis Pharmaceuticals, Inc. Compounds and methods for modulating gene expression
AU2007249805B2 (en) * 2006-05-12 2013-01-10 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
RU2559536C2 (ru) * 2007-03-24 2015-08-10 Джензим Корпорейшн Введение антисмысловых олигонуклеотидов, комплементарных человеческому аполипопротеину в
US20090023138A1 (en) * 2007-07-17 2009-01-22 Zila Biotechnology, Inc. Oral cancer markers and their detection
US8012678B2 (en) * 2007-07-24 2011-09-06 Wisconsin Alumni Research Foundation Biomarkers for human papilloma virus-associated cancer
CN102439171B (zh) 2008-12-22 2017-07-14 犹他大学研究基金会 单色多重定量pcr
US9107933B2 (en) 2009-03-16 2015-08-18 Isis Pharmaceuticals, Inc. Compositions and methods of targeting apolipoprotein B for the reduction of apolipoprotein C-III
ITBO20090554A1 (it) * 2009-08-27 2011-02-28 Maria Gabriella Fornaro Metodo per individuare la predisposizione al carcinoma della prostata.
EP2553463B1 (en) * 2010-03-26 2017-05-03 Hongzhi Zou Methods and materials for detecting colorectal neoplasm
PE20141565A1 (es) 2011-11-15 2014-10-25 Univ Miami Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello
AU2012362210A1 (en) * 2011-12-31 2014-08-21 Telomere Diagnostics, Inc. Saliva-derived measures of telomere abundance and sample collection device
ES2859645T3 (es) 2013-03-14 2021-10-04 Mayo Found Medical Education & Res Detección de neoplasia
ES2762860T3 (es) 2013-05-22 2020-05-26 Telomere Diagnostics Inc Medidas de abundancia de telómeros cortos
WO2015153284A1 (en) 2014-03-31 2015-10-08 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
BR112017014116A2 (pt) 2014-12-30 2018-03-06 Telomere Diagnostics Inc pcr quantitativo multiplex
US10030272B2 (en) 2015-02-27 2018-07-24 Mayo Foundation For Medical Education And Research Detecting gastrointestinal neoplasms
EP3274440A4 (en) 2015-03-27 2019-03-06 Exact Sciences Corporation PROOF OF DISEASES OF THE DISHES
WO2017040627A1 (en) 2015-08-31 2017-03-09 Mayo Foundation For Medical Education And Research Detecting gastric neoplasm
US10370726B2 (en) 2016-04-14 2019-08-06 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasia
CN116024334A (zh) 2016-04-14 2023-04-28 梅约医学教育与研究基金会 检测DMR试剂筛选IPMN-HGD、PanIN-3或PDAC的用途及试剂盒
KR20190140901A (ko) 2017-02-28 2019-12-20 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 전립선 암의 검출
CA3084584A1 (en) 2017-11-30 2019-06-06 Mayo Foundation For Medical Education And Research Detecting breast cancer
CN114885938A (zh) * 2022-02-25 2022-08-12 厦门迈威生物科技有限公司 一种浆膜腔积液脱落细胞保存液及其生产方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5527676A (en) 1989-03-29 1996-06-18 The Johns Hopkins University Detection of loss of the wild-type P53 gene and kits therefor
DE69032864T3 (de) 1989-03-29 2013-01-31 The Johns Hopkins University Nachweis des Ausfalls des Wildtyps des p53-Gens
CA2064555A1 (en) 1990-06-27 1991-12-28 Arnold J. Levine Probes for detecting mutant p53
AU662906B2 (en) 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
ES2210239T3 (es) 1992-04-01 2004-07-01 The Johns Hopkins University School Of Medicine Metodo para detectar acidos nucleicos de mamiferos aislados en heces y reactivos para el mismo.
ATE198358T1 (de) 1992-04-27 2001-01-15 Dartmouth College Detektion von gensequenzen in biologischen flüssigkeiten
US5561041A (en) * 1993-11-12 1996-10-01 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection by analysis of sputum
US6235470B1 (en) 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
CH686982A5 (fr) * 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
US5589579A (en) 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
MXPA00009654A (es) * 1994-08-31 2005-09-08 Univ Johns Hopkins Med Deteccion de secuencias de acidos nucleicos hipermutables en tejidos.
AU726045B2 (en) * 1996-08-28 2000-10-26 Johns Hopkins University School Of Medicine, The Method for detecting cell proliferative disorders
DE19712332A1 (de) * 1997-03-25 1998-10-01 Boehringer Mannheim Gmbh Verfahren zum Nachweis von Mikrosatelliten-Instabilität zur Tumordiagnostik
WO1998044158A1 (en) * 1997-03-28 1998-10-08 Epitope, Inc. Simultaneous collection of dna and non-nucleic analytes from oral fluids

Also Published As

Publication number Publication date
EP1062366A4 (en) 2002-05-08
US6235470B1 (en) 2001-05-22
JP2004159661A (ja) 2004-06-10
NO20004504D0 (no) 2000-09-08
EP1062366A1 (en) 2000-12-27
NO20004504L (no) 2000-11-08
US7601521B2 (en) 2009-10-13
AU2996999A (en) 1999-09-27
DE69940969D1 (de) 2009-07-23
US20020197608A1 (en) 2002-12-26
AU769035B2 (en) 2004-01-15
AU2003266475A1 (en) 2004-01-22
WO1999046408A1 (en) 1999-09-16
CA2323060A1 (en) 1999-09-16
ATE433498T1 (de) 2009-06-15
US20050009040A1 (en) 2005-01-13
JP2002505888A (ja) 2002-02-26
US7279312B2 (en) 2007-10-09
EP1062366B1 (en) 2009-06-10
US20080124729A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
HK1033765A1 (en) Detection of neoplasia by analysis of saliva
WO1997025068A3 (en) Mesothelin antigen and methods and kits for targeting it
AU5794498A (en) Releasable nonvolatile mass-label molecules
AU1671300A (en) Cancer detection method and reagents
AU4073297A (en) Methods and compositions for the detection of cervical cancer
CA2195396A1 (en) Genetic diagnosis of prostate cancer
IL84866A0 (en) Method for detecting tumors
NZ331866A (en) Compounds for immunotherapy and immunodiagnosis of prostate cancer
WO2001018252A3 (en) Methods for disease detection
AU3568289A (en) Detection of neu gene expression and products
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
AU6162999A (en) Apoptosis marker antibodies and methods of use
WO1994013701A3 (en) Delta-like gene expressed in neuroendocrine tumors
NZ298554A (en) A tumour suppressor gene (Hypermethylated in Cancer) HIC-1 and its use
WO1999036568A3 (de) Verfahren zum identifizieren von t-zell-stimulierenden proteinfragmenten
AU2135497A (en) Genetic markers and methods for the detection of escherichia coli serotype-0157:h7
ES2166822T3 (es) Procedimientos de seleccion de la enfermedad de crohn usando alelos de microsatelites de tnf.
AU2002363867A1 (en) Method and nucleic acids for the analysis of a lung cell proliferative disorder
WO1990008457A3 (en) Method of detecting small cell carcinoma and use of acyl-peptide hydrolase and coding sequences therefor
WO1997029199A3 (en) Prostate specific antigen peptides and uses thereof
EP0857780A4 (en) NOVEL PROTEINS SPECIFICALLY EXPRESSED IN LIVER CANCER, GENES ENCODING THESE PROTEINS, ANTIBODIES ACTIVE AGAINST THESE PROTEINS AND METHOD FOR DETECTING THE EXPRESSION OF THESE PROTEINS
CA2067797A1 (en) Production and use of human nm23 protein and antibodies therefor
WO2002083899A1 (fr) Genes lies au cancer
WO2002044417A3 (en) Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
GB9810084D0 (en) Proteins

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190309